Onderneming Renalytix Ai PLC London S.E.
Aandelen
GB00BYWL4Y04
Geavanceerde medische apparatuur & technologie
Vakgebied
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Artificial Intelligence-enabled in Vitro Diagnostics
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 2 | 100,0 % | 3 | 100,0 % | +26,61% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
James McCullough
FOU | Founder | 56 | 15-03-18 |
Howard Doran
PSD | President | 63 | 01-09-23 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15-03-18 |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 70 | 15-03-18 |
Joseph Hutson
PRN | Corporate Officer/Principal | - | 22-07-21 |
Sales & Marketing | - | 07-06-21 | |
Salim Hamir
SEC | Corporate Secretary | - | - |
Jed Fulk
SAM | Sales & Marketing | 64 | 07-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Levangie
BRD | Director/Board Member | 73 | 30-08-21 |
Chairman | 72 | 15-03-18 | |
James McCullough
FOU | Founder | 56 | 15-03-18 |
Fergus Fleming
CTO | Chief Tech/Sci/R&D Officer | 57 | 15-03-18 |
Erik Lium
BRD | Director/Board Member | 56 | 01-11-18 |
Catherine Coste
BRD | Director/Board Member | 58 | 30-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 154 368 191 | 94 984 051 ( 61,53 %) | 0 | 61,53 % |
Bedrijfsgegevens
![Adres Renalytix Ai PLC](https://cdn.zonebourse.com/static/address/47041179.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,79% | 16,26 mld. | |
-50,54% | 2,44 mld. | |
+25,26% | 1,98 mld. | |
-8,81% | 1,52 mld. | |
+26,25% | 1,3 mld. | |
-18,54% | 937 mln. | |
-32,14% | 775 mln. | |
-1,40% | 760 mln. | |
-26,54% | 615 mln. |